)
Patient Support & Organizations
Committed to Supporting Patients and Public Health
CSL collaborates with patient advocacy groups and public health organizations at the international, regional, national and local levels to promote quality medical care and services and to improve and expand educational and outreach efforts.
- CSL Behring partners with groups like the Jeffrey Modell Foundation, EURORDIS and NORD to help raise rare-disease awareness. Lack of awareness is a key factor in people being misdiagnosed or undiagnosed. Once diagnosed, CSL Behring offers a number of support services and programs for its products.
- CSL Seqirus aims to remind the public how serious flu can be in working with organizations like Families Fighting Flu.
- CSL Vifor collaborates with groups like the European Heart Failure Policy Network, ‘Mechanism for Coordinated Access to Orphan Medicines’ (MoCA) and European Alliance for Access to Safe Medicines to help ensure patients get the care they need. CSL Vifor also supports efforts to provide early access of investigational drugs for patients facing serious illnesses who have exhausted all available treatment options (unmet medical needs). Learn more about the managed access programs.
CSL Behring: Raising Awareness & Working on Public Policy
In Europe, CSL Behring partners with EURORDIS, the European Organization for Rare Diseases. EURORDIS is a patient-driven alliance of representatives from patient organizations and others active in the field of rare diseases. As a Member of the EURORDIS Round Table of Companies (ERTC) at the Ruby level, CSL Behring gave EURORDIS an unrestricted grant to support its communications activities. In addition, CSL Behring also contributed in the context of the EURORDIS Black Pearl Awards, the EURORDIS Membership Meeting (EMM) and the EURORDIS International Initiatives.
In the United States, CSL Behring partners with the National Organization for Rare Disorders (NORD), an umbrella organization of patient advocacy organizations dedicated to individuals with rare diseases. CSL Behring serves on the NORD Corporate Council, a group of innovative companies who have and are developing therapies for the treatment of rare disorders, which helps to find commonality and discuss legislative activity to ensure the continued development of rare disease therapies. CSL Behring has provided NORD with unrestricted grants in support of their annual Rare Disease Summit and to bolster its government affairs capabilities.
Patient Financial Assistance & Support Programs
CSL provides a variety of patient support and financial assistance programs to help patients get the therapies and support they need, including copay assistance, reimbursement support, help for uninsured/underinsured patients, and self-administration training.
Patient Advocacy Grants
No one knows their condition and the barriers they face better than our patients, and we believe in enabling them to be their own best advocates for better care. We offer a unique advocacy program, called Local Empowerment for Advocacy Development or LEAD Grants, in both the US and Europe, that help at the patient organization level.
For the Kids
Developed by CSL Behring, the Gettin' in the Game (GIG) Junior National Championship (JNC) was the first national golf and baseball competition designed specifically for the bleeding disorders community. The program gives children with bleeding disorders an opportunity to compete in golf, baseball and swimming and provides education and information-sharing opportunities for participants and their parents/caregivers.